Pediatrix Medical Group, Inc. (NYSE:MD) Receives $16.67 Average PT from Analysts

Key Points

• Pediatrix Medical Group has received a consensus rating of "Hold" from analysts, with four hold recommendations and two buy recommendations.
• The company's average twelve-month price target among brokerages is currently $16.67, reflecting recent stock price fluctuations.
• Pediatrix Medical Group reported earnings of $0.53 per share, exceeding expectations, but noted a year-over-year revenue decline of 7.1%.

Pediatrix Medical Group, Inc. (NYSE:MD - Get Free Report) has been assigned a consensus recommendation of "Moderate Buy" from the seven research firms that are presently covering the firm, MarketBeat reports. Four research analysts have rated the stock with a hold rating, two have given a buy rating and one has issued a strong buy rating on the company. The average 12-month price target among brokerages that have updated their coverage on the stock in the last year is $16.75.

MD has been the subject of a number of recent analyst reports. UBS Group increased their price target on shares of Pediatrix Medical Group from $16.00 to $16.50 and gave the company a "neutral" rating in a research note on Thursday, August 14th. Macquarie increased their price target on shares of Pediatrix Medical Group from $19.00 to $20.00 and gave the company an "outperform" rating in a research note on Thursday, May 8th. Finally, Zacks Research upgraded shares of Pediatrix Medical Group to a "strong-buy" rating in a research note on Monday, August 11th.

Hedge Funds Weigh In On Pediatrix Medical Group

Several large investors have recently modified their holdings of the stock. LPL Financial LLC increased its stake in shares of Pediatrix Medical Group by 4.9% during the fourth quarter. LPL Financial LLC now owns 92,828 shares of the company's stock worth $1,218,000 after purchasing an additional 4,295 shares during the period. Geode Capital Management LLC increased its stake in shares of Pediatrix Medical Group by 0.6% during the fourth quarter. Geode Capital Management LLC now owns 1,947,796 shares of the company's stock worth $25,562,000 after purchasing an additional 11,045 shares during the period. Wells Fargo & Company MN increased its stake in shares of Pediatrix Medical Group by 11.0% during the fourth quarter. Wells Fargo & Company MN now owns 66,028 shares of the company's stock worth $866,000 after purchasing an additional 6,521 shares during the period. Legal & General Group Plc grew its stake in shares of Pediatrix Medical Group by 2.2% in the fourth quarter. Legal & General Group Plc now owns 238,935 shares of the company's stock valued at $3,135,000 after acquiring an additional 5,033 shares in the last quarter. Finally, Renaissance Technologies LLC grew its stake in shares of Pediatrix Medical Group by 117.4% in the fourth quarter. Renaissance Technologies LLC now owns 838,800 shares of the company's stock valued at $11,005,000 after acquiring an additional 453,000 shares in the last quarter. 97.71% of the stock is owned by institutional investors.

Pediatrix Medical Group Stock Up 3.4%

NYSE MD traded up $0.5510 during trading hours on Thursday, hitting $16.5510. 461,223 shares of the company traded hands, compared to its average volume of 750,998. The business's 50-day moving average is $13.58 and its 200-day moving average is $13.86. Pediatrix Medical Group has a twelve month low of $10.06 and a twelve month high of $17.67. The company has a debt-to-equity ratio of 0.70, a quick ratio of 1.80 and a current ratio of 1.80. The stock has a market capitalization of $1.44 billion, a price-to-earnings ratio of 12.84 and a beta of 1.21.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last issued its quarterly earnings results on Tuesday, August 5th. The company reported $0.53 EPS for the quarter, beating the consensus estimate of $0.42 by $0.11. Pediatrix Medical Group had a return on equity of 18.94% and a net margin of 5.66%.The firm had revenue of $468.84 million during the quarter, compared to analysts' expectations of $464.37 million. During the same period in the prior year, the firm posted $0.34 earnings per share. The business's quarterly revenue was down 7.1% compared to the same quarter last year. Sell-side analysts anticipate that Pediatrix Medical Group will post 1.38 earnings per share for the current year.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.